Insight
H5N1 Pandemic preparedness: Building a comprehensive immunological toolbox
By: Martine Boyer, Patrick Rheault, Vitalie Samoil
Presented at: PEGS, the Protein Engineering Summit, May 12-16, 2025, Boston, MA
H1N1, a highly pathogenic avian influenza subtype, has caused severe poultry outbreaks and sporadic human transmission with mortality rates over 50%. As the virus evolves, the need for effective preparedness becomes urgent. Immunological tools play a central role, offering insights into disease mechanisms, advancing vaccines, enhancing diagnostics, and guiding therapeutics. This poster highlights key innovations to build a comprehensive toolbox for H5N1 pandemic preparedness.
Complete the form below to access this scientific poster.
Related Insights
Specifica Antibody Discovery Campaigns
Specifica Library Platform Transfer
Specifica Affinity Maturation & Developability Optimization
Discovery Sciences – Innovative Antibody Drug Discovery Services
Immunogenicity Assessment and Functional Testing of Candidate Therapeutics
Presented by Chloe Ackaert, PhD at AAPS PharmSci360 in 2023
Multiplex Immunoassays for Idiopathic Pulmonary Fibrosis
Unleashing the power of MHC Associated Peptide Proteomics: Immunogenicity Assessment of Oncology Drugs
In vitro functional evaluation of immuno-oncology drug candidates in customized bioassays
Monoclonal Antibodies Reagents
